1 Aggarwal, S. & Mortensen, O. V. Overview of Monoamine Transporters. Curr Protoc Pharmacol 79, 12.16.11-12.16.17, doi:10.1002/cpph.32 (2017).
2 Saier, M. H., Jr., Tran, C. V. & Barabote, R. D. TCDB: the Transporter Classification Database for membrane transport protein analyses and information. Nucleic Acids Res 34, D181-D186 (2006).
3 Bröer, S. & Gether, U. The solute carrier 6 family of transporters. Br J Pharmacol 167, 256-278, doi:10.1111/j.1476-5381.2012.01975.x (2012).
4 Rudnick, G. & Nelson, P. J. Platelet 5-hydroxytryptamine transport, an electroneutral mechanism coupled to potassium. Biochemistry 17, 4739-4742, doi:10.1021/bi00615a021 (1978).
5 Wise, R. A. Dopamine, learning and motivation. Nat Rev Neurosci 5, 483-494, doi:10.1038/nrn1406 (2004).
6 Sotnikova, T. D., Beaulieu, J. M., Gainetdinov, R. R. & Caron, M. G. Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter. CNS. Neurol. Disord. Drug Targets 5, 45-56 (2006).
7 Hansen, F. H. et al. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. J Clin Invest 124, 3107-3120, doi:10.1172/JCI73778 (2014).
8 Cook, E. H., Jr. et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56, 993-998 (1995).
9 Beuming, T. et al. The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci 11, 780-789, doi:10.1038/nn.2146 (2008).
10 Giros, B., Jaber, M., Jones, S. R., Wightman, R. M. & Caron, M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612 (1996).
11 Chen, R. et al. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc. Natl. Acad. Sci. U. S. A 103, 9333-9338 (2006).
12 Robertson, S. D., Matthies, H. J. G. & Galli, A. A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol Neurobiol 39, 73-80, doi:10.1007/s12035-009-8053-4 (2009).
13 Yamashita, A., Singh, S. K., Kawate, T., Jin, Y. & Gouaux, E. Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters. Nature 437, 215-223 (2005).
14 Forrest, L. R. & Rudnick, G. The rocking bundle: a mechanism for ion-coupled solute flux by symmetrical transporters. Physiology. (Bethesda. ) 24, 377-386, doi:24/6/377 [pii];10.1152/physiol.00030.2009 [doi] (2009).
15 Keyes, S. R. & Rudnick, G. Coupling of transmembrane proton gradients to platelet serotonin transport. J Biol Chem 257, 1172-1176 (1982).
16 Billesbølle, C. B. et al. Transition metal ion FRET uncovers K+ regulation of a neurotransmitter/sodium symporter. Nature Communications 7, 12755, doi:10.1038/ncomms12755 (2016).
17 Merkle, P. S. et al. Substrate-modulated unwinding of transmembrane helices in the NSS transporter LeuT. Sci Adv 4, eaar6179, doi:10.1126/sciadv.aar6179 (2018).
18 Khelashvili, G. et al. Conformational Dynamics on the Extracellular Side of LeuT Controlled by Na+ and K+ Ions and the Protonation State of Glu290. J Biol Chem 291, 19786-19799, doi:10.1074/jbc.M116.731455 (2016).
19 Zhang, Y. W. et al. Structural elements required for coupling ion and substrate transport in the neurotransmitter transporter homolog LeuT. Proc Natl Acad Sci U S A 115, E8854-e8862, doi:10.1073/pnas.1716870115 (2018).
20 Nielsen, A. K. et al. Substrate-induced conformational dynamics of the dopamine transporter. Nat Commun 10, 2714, doi:10.1038/s41467-019-10449-w (2019).
21 Penmatsa, A., Wang, K. H. & Gouaux, E. X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503, 85-90, doi:nature12533 [pii];10.1038/nature12533 [doi] (2013).
22 Pörzgen, P., Park, S. K., Hirsh, J., Sonders, M. S. & Amara, S. G. The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines. Mol Pharmacol 59, 83-95, doi:10.1124/mol.59.1.83 (2001).
23 Humphreys, C. J., Beidler, D. & Rudnick, G. Substrate and inhibitor binding and translocation by the platelet plasma membrane serotonin transporter. Biochem Soc Trans 19, 95-98, doi:10.1042/bst0190095 (1991).
24 Dukkipati, A., Park, H. H., Waghray, D., Fischer, S. & Garcia, K. C. BacMam system for high-level expression of recombinant soluble and membrane glycoproteins for structural studies. Protein Expr. Purif 62, 160-170, doi:S1046-5928(08)00213-1 [pii];10.1016/j.pep.2008.08.004 [doi] (2008).
25 Goehring, A. et al. Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. Nat. Protocols 9, 2574-2585 (2014).
26 Wyllie, D. J. & Chen, P. E. Taking the time to study competitive antagonism. Br J Pharmacol 150, 541-551, doi:10.1038/sj.bjp.0706997 (2007).
27 Newman, A. H., Zou, M. F., Ferrer, J. V. & Javitch, J. A. [3H]MFZ 2-12: a novel radioligand for the dopamine transporter. Bioorg Med Chem Lett 11, 1659-1661, doi:10.1016/s0960-894x(01)00271-2 (2001).
28 Skinner, J. J., Lim, W. K., Bédard, S., Black, B. E. & Englander, S. W. Protein dynamics viewed by hydrogen exchange. Protein Sci 21, 996-1005, doi:10.1002/pro.2081 (2012).
29 Wang, K. H., Penmatsa, A. & Gouaux, E. Neurotransmitter and psychostimulant recognition by the dopamine transporter. Nature 521, 322-327, doi:10.1038/nature14431 (2015).
30 Thomsen, R. P. et al. A large size-selective DNA nanopore with sensing applications. Nat Commun 10, 5655, doi:10.1038/s41467-019-13284-1 (2019).
31 Bohr, S. S., Thorlaksen, C., Kuhnel, R. M., Gunther-Pomorski, T. & Hatzakis, N. S. Label-Free Fluorescence Quantification of Hydrolytic Enzyme Activity on Native Substrates Reveals How Lipase Function Depends on Membrane Curvature. Langmuir 36, 6473-6481, doi:10.1021/acs.langmuir.0c00787 (2020).
32 Hatzakis, N. S. et al. How curved membranes recruit amphipathic helices and protein anchoring motifs. Nat Chem Biol 5, 835-841, doi:10.1038/nchembio.213 (2009).
33 Möller, I. R. et al. Conformational dynamics of the human serotonin transporter during substrate and drug binding. Nat Commun 10, 1687, doi:10.1038/s41467-019-09675-z (2019).
34 Mager, S. et al. Conducting states of a mammalian serotonin transporter. Neuron 12, 845-859 (1994).
35 Sonders, M. S., Zhu, S. J., Zahniser, N. R., Kavanaugh, M. P. & Amara, S. G. Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17, 960-974 (1997).
36 Herborg, F., Andreassen, T. F., Berlin, F., Loland, C. J. & Gether, U. Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes. Journal of Biological Chemistry 293, 7250-7262, doi:10.1074/jbc.RA118.001753 (2018).
37 Masson, G. R. et al. Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments. Nat Methods 16, 595-602, doi:10.1038/s41592-019-0459-y (2019).